A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Clinical trial NCT06822868 · RECRUITING

Trial details

NCT number: NCT06822868
Sponsor: Kai Hu
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Non-Hodgkin Lymphoma

Start date: 2025-02-10
Primary completion: 2025-09-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.